Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer
September 08, 2021 at 08:00 am EDT
Eloxx Pharmaceuticals, Inc. announced the appointment of Ali Hariri, M.D., as its chief medical officer, overseeing clinical development efforts for the company’s promising pipeline of therapies to treat rare diseases. Dr. Hariri will report to Vijay Modur, M.B.B.S., Ph.D., the company’s Head of Research and Development. Dr. Hariri was previously Senior Global Project Head in Rare Disease Clinical Development at Sanofi where he oversaw key functions responsible for advancing a number of investigational therapies along with full approval for on-market therapies within the Sanofi Genzyme specialty care business.